Mіnі-rеvіеw: Advаnсеs іn thе sуnthеsіs аnd bіоlоgісаl асtіvіtу оf bеnzоfurохаn аnd furохаn dеrіvаtіvеs

2025

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.15328/cb1391
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Benzofuroxan and furoxan derivatives are heterocyclic compounds well known for their ability to act as nitric oxide (NO) donors. Due to their NO-releasing properties, these compounds have attracted considerable attention for their antimicrobial, antiviral, and antitumor activities. Their potential use in treating cardiovascular, gastrointestinal, and neurodegenerative disorders further underscores their pharmacological relevance. Given the increasing research interest in these compounds, there is a need to consolidate recent findings related to their chemical properties and biological potential. This mini-review aims to provide an up-to-date overview of the synthetic strategies and bioactivities of benzofuroxan and furoxan derivatives. Rather than focusing on ring synthesis, this review highlights the reactivity of side-chain functional groups and the design of hybrid molecules. Representative examples of drug-like compounds are discussed, along with their biological profiles. The review also explores emerging directions in the development of novel NO donors based on these frameworks with improved pharmaceutical efficacy and controlled NO release.